Kane Biotech Inc (KNE) — Strategic Asset Allocation Index
Kane Biotech Inc (KNE) has a Strategic Asset Allocation Index of 500.5% as of June 2021. Strategic assets (PP&E of CA$1.51 Million plus long-term investments of CA$-) total CA$1.51 Million, measured against net assets of CA$301.79K. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Kane Biotech Inc Strategic Asset Allocation Index (2013–2020)
This chart shows how Kane Biotech Inc's Strategic Asset Allocation Index has evolved across 7 annual periods from 2013 to 2020. As of June 2021, the index stands at 500.5%, representing strategic assets of CA$1.51 Million against net assets of CA$301.79K CAD. Explore how efficiently does Kane Biotech Inc generate cash to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Kane Biotech Inc (2013–2020)
The table below presents the year-by-year Strategic Asset Allocation Index for Kane Biotech Inc from 2013 to 2020, covering 7 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see Kane Biotech Inc stock valuation.
| Year | SAAI | Strategic Assets (CAD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2020 | 15.2% | CA$162.85K | CA$162.85K | CA$- | CA$1.07 Million | ▲ +5.6 pp |
| 2019 | 9.5% | CA$79.78K | CA$79.78K | CA$- | CA$836.81K | ▲ +7.3 pp |
| 2017 | 2.2% | CA$60.28K | CA$60.28K | CA$- | CA$2.74 Million | ▼ -2.5 pp |
| 2016 | 4.7% | CA$63.09K | CA$63.09K | CA$- | CA$1.35 Million | ▼ -3.6 pp |
| 2015 | 8.3% | CA$39.76K | CA$39.76K | CA$- | CA$480.25K | ▲ +5.4 pp |
| 2014 | 2.9% | CA$38.67K | CA$38.67K | CA$- | CA$1.32 Million | ▼ -0.4 pp |
| 2013 | 3.3% | CA$42.24K | CA$42.24K | CA$- | CA$1.28 Million | — |